Lajaunias F[au] - Search Results

Year	Number of Results
1999	1
2000	1
2001	1
2002	2
2003	1
2005	2
2006	1
2013	2
2019	1
2022	0

1

PSP and NT-proCNP assessed for predisposition to infection.

Lajaunias F. Lajaunias F. Crit Care. 2013 Sep 5;17(5):450. doi: 10.1186/cc12883. Crit Care. 2013. PMID: 24007786 Free PMC article. No abstract available.

2

An experimental model of cryoglobulin-associated vasculitis in mice.

Pastore Y, Lajaunias F, Kuroki A, Moll T, Kikuchi S, Izui S. Pastore Y, et al. Among authors: lajaunias f. Springer Semin Immunopathol. 2001;23(3):315-29. doi: 10.1007/s002810100075. Springer Semin Immunopathol. 2001. PMID: 11591105 Review. No abstract available.

3

Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care.

Llewelyn MJ, Berger M, Gregory M, Ramaiah R, Taylor AL, Curdt I, Lajaunias F, Graf R, Blincko SJ, Drage S, Cohen J. Llewelyn MJ, et al. Among authors: lajaunias f. Crit Care. 2013 Mar 26;17(2):R60. doi: 10.1186/cc12588. Crit Care. 2013. PMID: 23531337 Free PMC article.

4

CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial.

Laterre PF, Colin G, Dequin PF, Dugernier T, Boulain T, Azeredo da Silveira S, Lajaunias F, Perez A, François B. Laterre PF, et al. Among authors: lajaunias f. Lancet Infect Dis. 2019 Jun;19(6):620-630. doi: 10.1016/S1473-3099(18)30805-3. Epub 2019 May 2. Lancet Infect Dis. 2019. PMID: 31056427

5

Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding.

Nitschke L, Lajaunias F, Moll T, Ho L, Martinez-Soria E, Kikuchi S, Santiago-Raber ML, Dix C, Parkhouse RM, Izui S. Nitschke L, et al. Among authors: lajaunias f. Int Immunol. 2006 Jan;18(1):59-68. doi: 10.1093/intimm/dxh349. Epub 2005 Nov 15. Int Immunol. 2006. PMID: 16291654

6

Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling.

Lajaunias F, Dayer JM, Chizzolini C. Lajaunias F, et al. Eur J Immunol. 2005 Jan;35(1):243-51. doi: 10.1002/eji.200425273. Eur J Immunol. 2005. PMID: 15597323 Free article.

7

Level of galactosylation determines cryoglobulin activity of murine IgG3 monoclonal rheumatoid factor.

Kuroki A, Kuroda Y, Kikuchi S, Lajaunias F, Fulpius T, Pastore Y, Fossati-Jimack L, Reininger L, Toda T, Nakata M, Kojima N, Mizuochi T, Izui S. Kuroki A, et al. Among authors: lajaunias f. Blood. 2002 Apr 15;99(8):2922-8. doi: 10.1182/blood.v99.8.2922. Blood. 2002. PMID: 11929783 Free article.

8

Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.

Lajaunias F, Ida A, Kikuchi S, Fossati-Jimack L, Martinez-Soria E, Moll T, Law CL, Izui S. Lajaunias F, et al. Arthritis Rheum. 2003 Jun;48(6):1612-21. doi: 10.1002/art.11021. Arthritis Rheum. 2003. PMID: 12794829 Free article.

9

Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice.

Mary C, Laporte C, Parzy D, Santiago ML, Stefani F, Lajaunias F, Parkhouse RM, O'Keefe TL, Neuberger MS, Izui S, Reininger L. Mary C, et al. Among authors: lajaunias f. J Immunol. 2000 Sep 15;165(6):2987-96. doi: 10.4049/jimmunol.165.6.2987. J Immunol. 2000. PMID: 10975807 Free article.

10

Differentially regulated expression and function of CD22 in activated B-1 and B-2 lymphocytes.

Lajaunias F, Nitschke L, Moll T, Martinez-Soria E, Semac I, Chicheportiche Y, Parkhouse RM, Izui S. Lajaunias F, et al. J Immunol. 2002 Jun 15;168(12):6078-83. doi: 10.4049/jimmunol.168.12.6078. J Immunol. 2002. PMID: 12055217 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results